Low vision readers depend on magnification, but magnification reduces the amount of text that can be overviewed and
hampers text navigation. In this study, we evaluate the effects that font variations letter spacing, letter width, and letter boldness have
on low vision reading. We tested 20 low-vision patients with age-related macular degeneration (AMD) and used the Radner Reading Chart, which
measures reading acuity (logRAD), maximum reading speed, and critical print size. The results demonstrated a small, but measurable effect of letter spacing and letter width on reading acuity near critical font sizes.
To inform our knowledge of the typographical variables of stroke weight, letter width, and letter spacing, and their effects on different age groups and reading scenarios, we used Radner Reading Chart, where we measured reading speed at different sizes, to compare the fonts KBH Text, KBH Display, and Gill Sans Light. The experiment showed that for older participants, reading Gill Sans resulted in faster reading speed compared to KBH Text. However, Gill Sans could not be recognized at small sizes by either the younger or older participants. For critical print size (CPS), older participants were better at reading small print sizes at a regular reading speed when the text was set in KBH Text than when it was set in Gill Sans. The findings indicate that older readers are more sensitive to font legibility differences than younger readers. We discuss the implications of different reading scenarios putting different demands on the fonts as well as the perspective of older readers benefitting from certain visual qualities of fonts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.